Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8035905rdf:typepubmed:Citationlld:pubmed
pubmed-article:8035905lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:8035905lifeskim:mentionsumls-concept:C0019588lld:lifeskim
pubmed-article:8035905lifeskim:mentionsumls-concept:C0020429lld:lifeskim
pubmed-article:8035905lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:8035905lifeskim:mentionsumls-concept:C0205099lld:lifeskim
pubmed-article:8035905lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:8035905pubmed:issue2lld:pubmed
pubmed-article:8035905pubmed:dateCreated1994-8-12lld:pubmed
pubmed-article:8035905pubmed:abstractTextThe effects of intracerebroventricular (i.c.v.) injection of histamine, the H1 agonist 2-methyl-histamine and the H2 agonist dimaprit were tested on carrageenin induced hyperalgesia by the Randall-Selitto paw pressure test in the rat. Treatment with histamine (0.1, 0.2, 0.4 mumol/rat, i.c.v.) 150 min after intraplantar carrageenin (0.1 ml of 1% solution) caused a significant increase of paw pressure thresholds in inflamed (but not in non-inflamed) paws. The magnitude and the duration of the antinociceptive effects of histamine were dose-dependent. Administration of 2-methyl-histamine (0.2, 0.4, 0.8, 1.0 mumol/rat, i.c.v.) and dimaprit (0.1, 0.2, 0.4, 0.8 mumol/rat, i.c.v.) also displayed dose-dependent blockade of carrageenin-induced hyperalgesia. Antinociceptive ED50 values calculated 30 min after drug treatments were: histamine 0.18 mumol/rat; 2-methyl-histamine 0.65 mumol/rat; dimaprit 0.33 mumol/rat. These data indicate that histamine through central H1 and H2 receptors exerts an inhibitory role in the control of nociception in pain resulting from inflammation.lld:pubmed
pubmed-article:8035905pubmed:languageenglld:pubmed
pubmed-article:8035905pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8035905pubmed:citationSubsetIMlld:pubmed
pubmed-article:8035905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8035905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8035905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8035905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8035905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8035905pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8035905pubmed:statusMEDLINElld:pubmed
pubmed-article:8035905pubmed:monthFeblld:pubmed
pubmed-article:8035905pubmed:issn0028-3908lld:pubmed
pubmed-article:8035905pubmed:authorpubmed-author:BragaP CPClld:pubmed
pubmed-article:8035905pubmed:authorpubmed-author:PecileAAlld:pubmed
pubmed-article:8035905pubmed:authorpubmed-author:NettiCClld:pubmed
pubmed-article:8035905pubmed:authorpubmed-author:GuidobonoFFlld:pubmed
pubmed-article:8035905pubmed:authorpubmed-author:VillanoVVlld:pubmed
pubmed-article:8035905pubmed:authorpubmed-author:SibiliaVVlld:pubmed
pubmed-article:8035905pubmed:issnTypePrintlld:pubmed
pubmed-article:8035905pubmed:volume33lld:pubmed
pubmed-article:8035905pubmed:ownerNLMlld:pubmed
pubmed-article:8035905pubmed:authorsCompleteYlld:pubmed
pubmed-article:8035905pubmed:pagination205-10lld:pubmed
pubmed-article:8035905pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8035905pubmed:meshHeadingpubmed-meshheading:8035905-...lld:pubmed
pubmed-article:8035905pubmed:meshHeadingpubmed-meshheading:8035905-...lld:pubmed
pubmed-article:8035905pubmed:meshHeadingpubmed-meshheading:8035905-...lld:pubmed
pubmed-article:8035905pubmed:meshHeadingpubmed-meshheading:8035905-...lld:pubmed
pubmed-article:8035905pubmed:meshHeadingpubmed-meshheading:8035905-...lld:pubmed
pubmed-article:8035905pubmed:meshHeadingpubmed-meshheading:8035905-...lld:pubmed
pubmed-article:8035905pubmed:meshHeadingpubmed-meshheading:8035905-...lld:pubmed
pubmed-article:8035905pubmed:meshHeadingpubmed-meshheading:8035905-...lld:pubmed
pubmed-article:8035905pubmed:meshHeadingpubmed-meshheading:8035905-...lld:pubmed
pubmed-article:8035905pubmed:meshHeadingpubmed-meshheading:8035905-...lld:pubmed
pubmed-article:8035905pubmed:meshHeadingpubmed-meshheading:8035905-...lld:pubmed
pubmed-article:8035905pubmed:year1994lld:pubmed
pubmed-article:8035905pubmed:articleTitleEvidence for an inhibitory role of central histamine on carrageenin-induced hyperalgesia.lld:pubmed
pubmed-article:8035905pubmed:affiliationDepartment of Pharmacology, Chemotherapy and Medical Toxicology, University of Milan, Italy.lld:pubmed
pubmed-article:8035905pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8035905pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed